BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25995617)

  • 1. Structural dynamics and inhibitor searching for Wnt-4 protein using comparative computational studies.
    Hammad MA; Azam SS
    Drug Des Devel Ther; 2015; 9():2449-61. PubMed ID: 25995617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study.
    El-Hachem N; Haibe-Kains B; Khalil A; Kobeissy FH; Nemer G
    Methods Mol Biol; 2017; 1598():391-403. PubMed ID: 28508374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stalis: A Computational Method for Template-Based Ab Initio Ligand Design.
    Lee HS; Im W
    J Comput Chem; 2019 Jun; 40(17):1622-1632. PubMed ID: 30829435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
    Forli S; Huey R; Pique ME; Sanner MF; Goodsell DS; Olson AJ
    Nat Protoc; 2016 May; 11(5):905-19. PubMed ID: 27077332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
    Good AC; Cheney DL
    J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Klotho peptide antagonists against Wnt3 and Wnt3a target proteins using combination of protein engineering, protein-protein docking, peptide docking and molecular dynamics simulations.
    Mirza SB; Ekhteiari Salmas R; Fatmi MQ; Durdagi S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):84-98. PubMed ID: 27766889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative modeling and virtual screening for the identification of novel inhibitors for myo-inositol-1-phosphate synthase.
    Azam SS; Sarfaraz S; Abro A
    Mol Biol Rep; 2014 Aug; 41(8):5039-52. PubMed ID: 24752405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products.
    Sun Y; Zhou H; Zhu H; Leung SW
    Sci Rep; 2016 Jan; 6():19312. PubMed ID: 26805727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
    PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
    J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP.
    Zacharias M
    Proteins; 2004 Mar; 54(4):759-67. PubMed ID: 14997571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets.
    Xu W; Lucke AJ; Fairlie DP
    J Mol Graph Model; 2015 Apr; 57():76-88. PubMed ID: 25682361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based computational approaches for small-molecule modulation of protein-protein interactions.
    Xu D; Wang B; Meroueh SO
    Methods Mol Biol; 2015; 1278():77-92. PubMed ID: 25859944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating ligand-based and protein-centric virtual screening of kinase inhibitors using ensembles of multiple protein kinase genes and conformations.
    Dixit A; Verkhivker GM
    J Chem Inf Model; 2012 Oct; 52(10):2501-15. PubMed ID: 22992037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of reverse docking for target prediction of marine compounds with anti-tumor activity.
    Chen F; Wang Z; Wang C; Xu Q; Liang J; Xu X; Yang J; Wang C; Jiang T; Yu R
    J Mol Graph Model; 2017 Oct; 77():372-377. PubMed ID: 28950183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.